ZYUS Share Price Performance
CA$0.49
-0.20 (-29.29%)
Price CA$0.49
Share Pricen/a
ZYUS Life Sciences Corporation Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 0 Fair Values set on narratives written by author
ZYUS Community Narratives
There are no narratives available yet.
There are no community narratives available.
Trending Discussion
No trending discussion available.
Recently Updated Narratives
No recently updated narratives available.
Snowflake Analysis
ZYUS Life Sciences Corporation Key Details
Last Reported Earnings
Mar 31, 2026
Next Reporting Earnings
n/a
- -0.26
- -4.36%
- -5,044.55%
- -83.0%
About ZYUS
- Founded
- 2018
- Employees
- n/a
- CEO
- WebsiteView website
ZYUS Life Sciences Corporation manufactures and distributes cannabinoid-based therapeutics and product candidates for medical and adult recreational. The company offers Trichomylin, a softgel capsules with fixed dose combination of cannabinoids formulated that is phase 2a clinical trial for the treatment of chronic pain in adults caused due to musculoskeletal injuries, arthritis, and cancer. It operates in Canada, the United States, Australia, and the European Union. ZYUS Life Sciences Corporation was founded in 2018 and is headquartered in Saskatoon, Canada.
